Study guide

1.3 Acute vs. Chronic Wounds & Etiology Classification

NAWCCB WCC Wound Care Certified Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

About the NAWCCB WCC Exam How to Use This Study Guide

2 Assessment: Skin & Tissue Foundations

1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric

3 Assessment: Diagnostic Tools & Risk Assessment

2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas

4 Treatment: Dressing Selection & Debridement Modalities

3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical

5 Treatment: Advanced Therapies & Specialized Management

4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT

6 Reevaluation & Wound Healing Trajectory

5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence

7 Risk Reduction & Prevention Strategies

6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment

8 Patient & Caregiver Education

7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media

9 Administration & Program Management

8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization

10 Legal, Ethical, & Scope of Practice

9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection

1.3 Acute vs. Chronic Wounds & Etiology Classification

Key Takeaways Explain This Topic AI

Acute wounds follow an orderly, timely reparative process progressing to structural integrity within 4 to 12 weeks, whereas chronic wounds stall in the inflammatory phase past 12 weeks.

Chronic wound fluid is pathophysiologically distinct, exhibiting elevated levels of matrix metalloproteinases (MMPs), low levels of TIMPs, degraded growth factors, and senescent, non-responsive fibroblasts.

Arterial ulcers typically present on distal extremities/toes with punch-out borders, pale/gangrenous base, severe ischemic pain elevated by leg elevation, and an Ankle-Brachial Index (ABI) < 0.8.

Venous leg ulcers occur primarily in the gaiter area (gaiter zone), presenting with irregular shallow borders, heavy exudate, ruddy granulation tissue, and signs of venous hypertension (stasis dermatitis, hemosiderin staining, lipodermatosclerosis).

Diabetic foot ulcers stem from a triad of peripheral neuropathy (sensory, motor, autonomic), microvascular/macrovascular disease, and repetitive mechanical trauma over bony prominences.

Last updated: August 2026

Acute vs. Chronic Wounds & Etiology Classification

Accurate wound assessment begins with establishing whether a wound is acute or chronic , followed by determining its underlying clinical etiology . Misidentifying wound etiology—such as applying high-level compression therapy to an undiagnosed ischemic arterial ulcer—can cause severe tissue necrosis or limb loss. Clinicians must integrate biological understanding with precise physical examination parameters.

Biological Comparison: Acute vs. Chronic Wounds

An acute wound is caused by external trauma or surgical intervention and follows an orderly, timely repair process that restores structural and functional integrity within 4 to 12 weeks . In contrast, a chronic wound fails to progress through the normal stages of healing, stalling persistently in the inflammatory phase beyond 12 weeks. +-----------------------------------------------------------------------------------+

  • | ACUTE WOUND ENVIRONMENT |
  • | - Proteases (MMPs) & Inhibitors (TIMPs) in balanced ratio (~1:1) |
  • | - High levels of intact, bio-active growth factors (PDGF, TGF-β, VEGF) |
  • | - Highly proliferative, responsive fibroblasts & endothelial cells |
  • | - Minimal bacterial load; absent biofilm |
  • +-----------------------------------------------------------------------------------+

vs.

  • +-----------------------------------------------------------------------------------+
  • | CHRONIC WOUND ENVIRONMENT |
  • | - Pathologically elevated MMPs (up to 100-fold higher than acute wounds) |
  • | - Severe deficiency of TIMPs; massive degradation of growth factors & fibronectin |
  • | - Phenotypically senescent, non-responsive fibroblasts |
  • | - Persistent bacterial biofilm & chronic polymicrobial bioburden |
  • +-----------------------------------------------------------------------------------+
  • The Hostile Chronic Microenvironment

Chronic wound fluid contains high concentrations of pro-inflammatory cytokines ( TNF-α, IL-1β, IL-6 ) and excess neutrophil elastase. Elevated matrix metalloproteinases (specifically MMP-2, MMP-8, and MMP-9 ) rapidly degrade newly synthesized extracellular matrix components and cleave cell-surface growth factor receptors. Fibroblasts within chronic wound margins become phenotypically senescent —they remain metabolically active but lose the capacity to divide, migrate, or synthesize collagen in response to growth factor signals.

Wound Etiology Classification & Differential Diagnosis

Major chronic wound etiologies display distinct clinical patterns based on underlying pathophysiology:

Etiology Primary Pathophysiology Classic Anatomical Location Border & Base Features Exudate Volume Periwound Features Vascular & Neurological Status

Venous Leg Ulcer (VLU) Ambulatory venous hypertension, valve incompetence, calf muscle pump failure. Lower leg gaiter region (ankle to mid-calf, medial malleolus). Shallow, irregular, sloping margins; ruddy red granulation, yellow fibrinous slough. Moderate to Heavy (copious serous) Hemosiderin staining, stasis dermatitis, lipodermatosclerosis, atrophie blanche. Normal pedal pulses; ABI 0.9–1.3 (unless mixed arterial/venous).

Arterial Ischemic Ulcer Atherosclerotic peripheral artery disease (PAD), arterial occlusion, ischemia. Distal extremities: toes, interdigital spaces, lateral malleolus, heel. "Punched-out" , well-demarcated round margins; pale, gray, or black dry eschar base. Scant to None (dry) Thin, shiny, hairless skin; dystrophic nails; dependent rubor; pallor on elevation. Absent or diminished pulses ; ABI < 0.8 (< 0.5 = severe ischemia).

Diabetic Neuropathic Ulcer Triad: Sensory LOPS, motor deformity, autonomic dryness + repetitive trauma. Plantar surface of foot, metatarsal heads, plantar heel, dorsal toes. Deep, round margin surrounded by thick hyperkeratotic callus . Variable (Scant to Moderate) Dry, anhidrotic fissured skin; Charcot foot deformities (claw/hammer toes). Sensory loss ( 10g Monofilament LOPS ); variable pulse status.

Pressure Injury Unrelieved intense pressure and/or shear forces over bony prominences. Sacrum, ischium, trochanter, calcaneus (heel), occiput, scapula. Depth matches NPIAP Stage (1–4, Unstageable, DTPI). Variable (Minimal to Heavy) Non-blanchable erythema, induration, localized temperature alteration. Pulses usually present unless concurrent PAD is present.

  • Detailed Clinical Profiles of Major Etiologies
  • 1. Venous Leg Ulcers (VLUs)

Venous leg ulcers represent 70% to 80% of all lower extremity ulcers. Incompetent deep, superficial, or perforating vein valves prevent effective venous return, causing elevated venous pressure during ambulation ( ambulatory venous hypertension ). Fluid, fibrinogen, and red blood cells leak into interstitial tissues. Erythrocytes lyse, releasing hemoglobin that breaks down into hemosiderin , creating permanent dark brown/purple hyperpigmentation around the ankle and gaiter area.

Over time, chronic subcutaneous fat inflammation causes severe fibrosis and tissue contraction, resulting in lipodermatosclerosis (giving the leg an inverted champagne bottle shape). Patients experience dull aching pain or leg heaviness that is relieved by leg elevation .

2. Arterial Ischemic Ulcers

Arterial ulcers account for 10% to 15% of lower extremity wounds. Inadequate arterial blood flow impairs tissue oxygen delivery, leading to ischemic necrosis. Pain is severe, constant, and exacerbated by leg elevation or exercise (claudication). Patients often sleep in a chair or hang their foot over the bed edge to use gravity to augment arterial perfusion.

Physical exam reveals dependent rubor (foot turns deep red when hanging dependently due to maximal compensatory capillary vasodilation) and elevation pallor (foot turns pale white when raised 45 ∘ 45^\circ 4 5 ∘ for 60 seconds). [ Leg Elevated 45° ] -----> Significant Pallor (Ischemic blood depletion)

  • [ Leg Dependent ] -----> Dependent Rubor (Compensatory reactive hyperemia)
  • 3. Diabetic Foot Ulcers (DFUs) & The Neuropathic Triad

Diabetic foot ulcers stem from a complex interaction of systemic metabolic abnormalities:

Sensory Neuropathy: Loss of Protective Sensation (LOPS) prevents recognition of minor trauma (e.g., a pebble inside a shoe or repetitive high pressure).

Motor Neuropathy: Atrophy of intrinsic foot muscles causes biomechanical imbalance, resulting in clawing of toes, prominent metatarsal heads, and high plantar pressure focal points.

Autonomic Neuropathy: Loss of sympathetic innervation inhibits sweat and oil gland secretion, resulting in dry, anhidrotic skin prone to deep cracking and fissuring.

Loading diagram... Etiology Decision Tree for Lower Extremity Ulcers

Diagnostic Testing Cutoffs for Arterial Safety

Prior to applying any compression therapy or performing aggressive sharp debridement on lower extremity wounds, vascular adequacy MUST be objectively confirmed using non-invasive arterial testing:

Ankle-Brachial Index (ABI):

0.91 to 1.30: Normal arterial perfusion; safe for full high-level compression (30–40 mmHg).

0.80 to 0.90: Mild arterial disease; full compression (30–40 mmHg) is still permitted, with monitoring of distal capillary refill, color, and sensation.

0.50 to 0.79: Moderate arterial disease; full compression is unsafe, but modified reduced compression (20–30 mmHg) is indicated under specialist supervision; obtain a vascular consult.

< 0.50: Severe arterial disease / critical limb ischemia; high risk of necrosis; compression CONTRAINDICATED.

> 1.30: Non-compressible calcified vessels (common in diabetes/ESRD); requires Toe-Brachial Index ( TBI , normal > 0.70) or Transcutaneous Oximetry ( TcPO2 , normal > 40 mmHg; < 30 mmHg indicates impaired healing).